Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$5.1M
4 rounds on record
Latest round
$4.5M
Venture round · Aug 2025 · 13 mo ago
Grants
$749k
1 grant · CORDIS
Backers
1
Pegasus Capital Advisors - Impact Investment Manager
The money's age
Due for its next round
13 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 29, 2025
Board appointment Rod Wolford, Director · SEC Form D
Dec 21, 2016
Board appointment Rob Wolford, Director · SEC Form D
2016
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2025 | $4.5M | — | SEC Form D |
| Debt Financing | Mar 2019 | $835k | — | SEC Form D |
| Grant | Sep 2016 | $749k | — | CORDIS |
| Venture round | Sep 2016 | $650k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Liberate Medical, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Angus McLachlanExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Sustanix develops novel biomolecules for advanced biomaterials, takes it from lab to industrial scale.

Discover the power of your breath with Alveos One - a lightweight wearable respiratory monitor that helps you connect with your health, one…

Exhalon, where precision medicine meets real-time breath analysis.

MedRhythms develops next-generation neurotherapeutics and medical devices that deliver rhythmic auditory stimulation (RAS) to support…

Criticore Electrical Services ensures reliability and safety with expert electrical solutions for critical, technically advanced facilities.

Neuro20 FDA cleared neuromuscular therapy transforms rehab, improving outcomes for MS, stroke, spinal injuries and more.
People

Angus McLachlan
Executive Officer, Director

Cedric Francois
Director

Alec Machiels
Director

Rob Wolford
Director

John Landry
Director

John Moore
Director

Rod Wolford
Director

Jennifer Landis
Director

Andrew Offer
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Pegasus Capital Advisors - Impact Investment Manager 




